Professional Documents
Culture Documents
qxd
10/8/07
3:27 PM
Page 80
IVTJVT1107.qxd
10/8/07
3:27 PM
Page 81
Irish Republic
Irish Medicines Board: Guide to Control and Monitoring
of Storage and Transportation Temperature Conditions for
Medicinal Products and Active Substances
PDA Technical Report No. 39
Cold chain guidance for medicinal products: maintaining the quality of temperature-sensitive products
through the transportation environment.
World Health Organization
Guidelines on Good Distribution Practices (GDPs)
are incorporated into volume 2, good manufacturing
practices and inspections, in Quality Assurance of Pharmaceuticals.
Canada
Food and Drug Regulations, Section C.02.015
Guidelines for Temperature Control of Drug Products
during Storage and Transportation (Guide - 0069)
Storage is a critical parameter in maintaining the
quality, safety, and efficacy of a medical product.
Storage condition is an important parameter to
maintaining the stability of the product.
Product must be stored in accordance with the requirements of its marketing authorization.
QUALIFICATION PARAMETERS
Normally, the Design Qualification (DQ), Installation
Qualification (IQ), and Operational Qualifications (OQ)
of the cold room are performed prior to the Performance
Qualification (PQ). The IQ/OQ of the chamber are easy
to perform and document, and a majority of pharmaceutical manufacturers comply with this requirement. The
supplier of the equipment also helps in performing these
qualification tests for IQ and OQ.
Now the question arises as to why and how the performance of the cold storerooms or chambers should be
qualified.
The purpose of the PQ of the cold room is to establish
N ove m b e r 2 0 0 7 Vo l u m e 1 4 , N u m b e r 1
81
IVTJVT1107.qxd
10/8/07
3:27 PM
Page 82
TEMPERATURE MAPPING
The temperature mapping is accomplished by using
temperature indicating probes coupled with a data logger
for data accusation. Questions may be asked regarding
the number of probes to be utilized and their placement
in the cold room for temperature mapping in the empty
room and the loaded room. The basic consideration
should be that the probes are distributed uniformly in the
room and should cover all the vertical planes. A minimum of fifteen (15) probes were considered adequate for
mapping of the temperature of the cold room to verify its
performance1.
Justification for Probe Locations
Probe location should be decided logically, strategically, and scientifically. The following locations cover
the entire room:
PERFORMANCE QUALIFICATION
STUDIES
Probe No 3:
Near to the door opening
Probe No 4:
At the centre of the room
STUDY METHODOLOGY
Probe No 1:
External environment outside the cold room
Probe No 2:
To calibrate along with the in-built temperature
and humidity probe of the room
Probes No 5, 6, 7, 8:
Top layer four corners of the room, but not at
the extreme corners
Probes No 9, 10, 11, 12:
Bottom layer four corners of the room,
82
IVTJVT1107.qxd
10/8/07
3:27 PM
Page 83
Figure 1
Optimum Probe Placement in a Cold Room
Blower
2
6
14
Inbuild Probe
4
10
7
12
15
13
3
11
Door
SIMULATIONS
The following worst-case conditions should be simulated:
For Power Failure Condition
A power failure study should be conducted at a peak
N ove m b e r 2 0 0 7 Vo l u m e 1 4 , N u m b e r 1
83
IVTJVT1107.qxd
10/8/07
3:27 PM
Page 84
CONCLUSION
The temperature for the cold room or chamber is the
critical parameter, since excursions in temperature conditions may affect the quality of stored material(s). It is essential, therefore, to qualify cold room performance
under worst-case scenarios. The approach described
above for conducting the performance qualification of
such cold rooms or chambers, with the consideration of
all possible challenges that may have a bearing on the desired acceptance criteria addresses each potential issue.
Conducting the studies following the methodology outlined, the impact of situations such as opening the door,
or power failure for a given period can be known. Further,
through these procedures, it is possible to identify the hot
spot and cold spot and the time required to regain the desired temperature conditions if disturbed because of adverse conditions.
REFERENCES
1. Michael J.A., Anderson N.R., Sterilization Validation. In
R.A.Nash, A.H.Wachter, eds., Pharmaceutical Process
Validation 3rd Ed. New York: Marcel Dekker, PP. 100(2003).
2. Food and Drug Administration, 21CFR 211.142 and
211.150 (Storage and Distribution).
3. The United States Pharmacopeia, Chapter 1079: Good
Storage and Shipping Practices.
4. Medicines and Healthcare Products Regulatory Agency,
RE-QUALIFICATION
84
IVTJVT1107.qxd
10/8/07
3:27 PM
Page 85
DQ
Design Qualification
GDP
IQ
Installation Qualification
MHRA
OQ
Operational Qualification
PDA
PQ
Performance Qualification
PUF
Polyurethane Foam
SOP
USP
N ove m b e r 2 0 0 7 Vo l u m e 1 4 , N u m b e r 1
85